Is fragment-based graph a better graph-based molecular representation for drug design? A comparison study of graph-based models
Baiyu Chen,Ziqi Pan,Minjie Mou,Yuan Zhou,Wei Fu
DOI: https://doi.org/10.1016/j.compbiomed.2023.107811
IF: 7.7
2024-01-03
Computers in Biology and Medicine
Abstract:Graph Neural Networks (GNNs) have gained significant traction in various sectors of AI-driven drug design. Over recent years, the integration of fragmentation concepts into GNNs has emerged as a potent strategy to augment the efficacy of molecular generative models . Nonetheless, challenges such as symmetry breaking and potential misrepresentation of intricate cycles and undefined functional groups raise questions about the superiority of fragment-based graph representation over traditional methods. In our research, we undertook a rigorous evaluation, contrasting the predictive prowess of eight models—developed using deep learning algorithms—across 12 benchmark datasets that span a range of properties. These models encompass established methods like GCN, AttentiveFP, and D-MPNN, as well as innovative fragment-based representation techniques. Our results indicate that fragment-based methodologies, notably PharmHGT, significantly improve model performance and interpretability, particularly in scenarios characterized by limited data availability. However, in situations with extensive training, fragment-based molecular graph representations may not necessarily eclipse traditional methods. In summation, we posit that the integration of fragmentation, as an avant-garde technique in drug design, harbors considerable promise for the future of AI-enhanced drug design.
engineering, biomedical,computer science, interdisciplinary applications,mathematical & computational biology,biology